Cebu Doctors’ University Hospital, known as Cebu Doctors' Hospital until 2006, is a major tertiary private hospital in Cebu City, Philippines. The 300-bed hospital was inaugurated on August 20, 1972.

During the past decade, Cebu Doctors University Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 16 clinical trials were completed, i.e. on average, 94.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 11 clinical trials were completed. i.e. 157.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cebu Doctors University Hospital" #1 sponsor was "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 4 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cebu Doctors University Hospital" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Actoverco" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Cristcot HCA LLC" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Cebu Doctors University Hospital" are "Arthritis, Psoriatic" (2 trials), "Epilepsy, Partial Seizures" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Breast Cancer" (1 trials) and "Caloric Deficit" (1 trials). Many other conditions were trialed in "Cebu Doctors University Hospital" in a lesser frequency.

Most popular intervention types in "Cebu Doctors University Hospital" are "Drug" (23 trials), "Biological" (3 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Paclitaxel" (4 trials), "Carboplatin" (3 trials), "Baricitinib" (2 trials) and "Bismuth-Containing Quadruple Therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cebu Doctors University Hospital" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cebu Doctors University Hospital". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Cebu Doctors University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cebu Doctors University Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".